Usefulness of Fibrinogen/Fibrin Degradation Product to Predict Poor One-Year Outcome of Medically Treated Patients With Acute Type B Aortic Dissection

American Journal of Cardiology

Volumn 101, Issue 9, 2008, Pages 1341-1344

  Kitada, Shuichi ^a   Akutsu, Koichi ^a   Tamori, Yuiichi ^a   Yoshimuta, Tsuyoshi ^a   Hashimoto, Hideki ^b   Takeshita, Satoshi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN DEGRADATION PRODUCT; FIBRINOGEN;

ADULT; AGED; ANEURYSM RUPTURE; AORTA ANEURYSM; AORTA DISSECTION; AORTA RUPTURE; ARTICLE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; FEMALE; HUMAN; LIMB ISCHEMIA; MALE; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE;

ACUTE DISEASE; AGED; ANEURYSM, DISSECTING; ANEURYSM, RUPTURED; AORTIC ANEURYSM; CHI-SQUARE DISTRIBUTION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 43049130302     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.12.036     Document Type: Article

References (11)

1. Makita S., Ohira A., Tachieda R., Itoh S., Moriai Y., Yoshioka K., Niinuma H., Nakamura M., and Hiramori K. Behavior of C-reactive protein levels in medically treated aortic dissection and intramural hematoma. Am J Cardiol 86 (2000) 242-244
2. Juvonen T., Ergin M.A., Galla J.D., Lansman S.L., McCullough J.N., Nguyen K., Bodian C.A., Ehrlich M.P., Spielvogel D., Klein J.J., and Griepp R.B. Risk factors for rupture of chronic type B dissections. J Thorac Cardiovasc Surg 117 (1999) 776-786
3. Masuda Y., Yamada Z., Morooka N., Watanabe S., and Inagaki Y. Prognosis of patients with medically treated aortic dissections. Circulation 84 (1991) III7-III13
4. Genoni M., Paul M., Tavakoli R., Kunzli A., Lachat M., Graves K., Seifert B., and Turina M. Predictors of complications in acute type B aortic dissection. Eur J Cardiothorac Surg 22 (2002) 59-63
5. Sueyoshi E., Sakamoto I., Hayashi K., Yamaguchi T., and Imada T. Growth rate of aortic diameter in patients with type B aortic dissection during the chronic phase. Circulation 110 (2004) II256-II261
6. Akutsu K., Nejima J., Kiuchi K., Sasaki K., Ochi M., Tanaka K., and Takano T. Effects of the patent false lumen on the long-term outcome of type B acute aortic dissection. Eur J Cardiothorac Surg 26 (2004) 359-366
7. Marui A., Mochizuki T., Mitsui N., Koyama T., Kimura F., and Horibe M. Toward the best treatment for uncomplicated patients with type B acute aortic dissection: a consideration for sound surgical indication. Circulation 100 (1999) II275-II280
8. Onitsuka S., Akashi H., Tayama K., Okazaki T., Ishihara K., Hiromatsu S., and Aoyagi S. Long-term outcome and prognostic predictors of medically treated acute type B aortic dissections. Ann Thorac Surg 78 (2004) 1268-1273
9. Hagan P.G., Nienaber C.A., Isselbacher E.M., Bruckman D., Karavite D.J., Russman P.L., Evangelista A., Fattori R., Suzuki T., Oh J.K., et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 283 (2000) 897-903
10. Kato M., Bai H., Sato K., Kawamoto S., Kaneko M., Ueda T., Kishi D., and Ohnishi K. Determining surgical indications for acute type B dissection based on enlargement of aortic diameter during the chronic phase. Circulation 92 (1995) II107-II112
11. Schillinger M., Domanovits H., Bayegan K., Holzenbein T., Grabenwoger M., Thoenissen J., Roggla M., and Mullner M. C-reactive protein and mortality in patients with acute aortic disease. Intensive Care Med 28 (2002) 740-745